"MCF-7 Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An estrogen responsive cell line derived from a patient with metastatic human breast ADENOCARCINOMA (at the Michigan Cancer Foundation.)
| Descriptor ID |
D061986
|
| MeSH Number(s) |
A11.251.210.190.630
|
| Concept/Terms |
MCF-7 Cells- MCF-7 Cells
- Cell, MCF-7
- Cells, MCF-7
- MCF 7 Cells
- MCF-7 Cell
- MCF7 Cells
- Cell, MCF7
- Cells, MCF7
- MCF7 Cell
- Michigan Cancer Foundation 7 Cells
|
Below are MeSH descriptors whose meaning is more general than "MCF-7 Cells".
Below are MeSH descriptors whose meaning is more specific than "MCF-7 Cells".
This graph shows the total number of publications written about "MCF-7 Cells" by people in this website by year, and whether "MCF-7 Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 2 | 2 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 11 | 11 |
| 2015 | 0 | 13 | 13 |
| 2016 | 0 | 8 | 8 |
| 2017 | 0 | 5 | 5 |
| 2018 | 0 | 2 | 2 |
| 2019 | 0 | 4 | 4 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "MCF-7 Cells" by people in Profiles.
-
Manne RK, Agrawal Y, Malonia SK, Banday S, Edachery S, Patel A, Kumar A, Shetty P, Santra MK. FBXL20 promotes breast cancer malignancy by inhibiting apoptosis through degradation of PUMA and BAX. J Biol Chem. 2021 10; 297(4):101253.
-
Cui J, Liu Q, Sendinc E, Shi Y, Gregory RI. Nucleotide resolution profiling of m3C RNA modification by HAC-seq. Nucleic Acids Res. 2021 03 18; 49(5):e27.
-
Zhang CH, Liu H, Zhao WL, Zhao WX, Zhou HM, Shao RG. G3BP1 promotes human breast cancer cell proliferation through coordinating with GSK-3? and stabilizing ?-catenin. Acta Pharmacol Sin. 2021 11; 42(11):1900-1912.
-
Barney LE, Hall CL, Schwartz AD, Parks AN, Sparages C, Galarza S, Platt MO, Mercurio AM, Peyton SR. Tumor cell-organized fibronectin maintenance of a dormant breast cancer population. Sci Adv. 2020 03; 6(11):eaaz4157.
-
Li F, Miao L, Xue T, Qin H, Mondal S, Thompson PR, Coonrod SA, Liu X, Zhang X. Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells. J Exp Clin Cancer Res. 2019 Oct 10; 38(1):414.
-
Nama S, Muhuri M, Di Pascale F, Quah S, Aswad L, Fullwood M, Sampath P. MicroRNA-138 is a Prognostic Biomarker for Triple-Negative Breast Cancer and Promotes Tumorigenesis via TUSC2 repression. Sci Rep. 2019 09 03; 9(1):12718.
-
Kalasin S, Browne EP, Arcaro KF, Santore MM. Surfaces that Adhesively Discriminate Breast Epithelial Cell Lines and Lymphocytes in Buffer and Human Breast Milk. ACS Appl Mater Interfaces. 2019 May 08; 11(18):16347-16356.
-
Hill LK, Frezzo JA, Katyal P, Hoang DM, Ben Youss Gironda Z, Xu C, Xie X, Delgado-Fukushima E, Wadghiri YZ, Montclare JK. Protein-Engineered Nanoscale Micelles for Dynamic 19F Magnetic Resonance and Therapeutic Drug Delivery. ACS Nano. 2019 03 26; 13(3):2969-2985.
-
Hong D, Fritz AJ, Finstad KH, Fitzgerald MP, Weinheimer A, Viens AL, Ramsey J, Stein JL, Lian JB, Stein GS. Suppression of Breast Cancer Stem Cells and Tumor Growth by the RUNX1 Transcription Factor. Mol Cancer Res. 2018 12; 16(12):1952-1964.
-
Alhamami M, Cheng W, Lyu Y, Allen C, Zhang XA, Cheng HL. Manganese-porphyrin-enhanced MRI for the detection of cancer cells: A quantitative in vitro investigation with multiple clinical subtypes of breast cancer. PLoS One. 2018; 13(5):e0196998.